Category: Pharmaceuticals
Global Pharmaceuticals
-
Indium
... 6.1% over the analysis period 2024-2030. Primary Indium, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$286.6 Million by the end of the analysis period. Growth ... Read More
-
Life Sciences BPO
... at a CAGR of 6.5% over the analysis period 2024-2030. Pharmaceutical Outsourcing Services, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$281.8 Billion by the end ... Read More
-
LNG Tank Containers
... at a CAGR of 5.6% over the analysis period 2024-2030. Marine Transportation, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$199.6 Million by the end of ... Read More
-
Loader Cranes
... CAGR of 5.0% over the analysis period 2024-2030. Construction End-Use, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$2.8 Billion by the end of the analysis ... Read More
-
Metal Nanoparticles
... CAGR of 9.1% over the analysis period 2024-2030. Chemical Process, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$2.2 Billion by the end of the analysis ... Read More
-
Needles
... 4.9% over the analysis period 2024-2030. Conventional Needles, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$6.6 Billion by the end of the analysis period. Growth ... Read More
-
Neuroprosthetics
... 11.9% over the analysis period 2024-2030. Spinal Cord Stimulation Technique, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$11.7 Billion by the end of the analysis ... Read More
-
Nucleating and Clarifying Agents
... 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Polypropylene Polymer, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$2.2 Billion by the ... Read More
-
Oncology Information Systems
... at a CAGR of 6.2% over the analysis period 2024-2030. Software Component, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$5.5 Billion by the end of ... Read More
-
Ophthalmic Femtosecond Lasers
... at a CAGR of 4.6% over the analysis period 2024-2030. Ophthalmic Femtosecond Laser Consumables & Accessories, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$666.4 Million ... Read More
-
Orthopedic Software
... CAGR of 6.4% over the analysis period 2024-2030. Orthopedic PACS, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$219.4 Million by the end of the analysis ... Read More
-
Pediatric Interventional Cardiology Devices
... 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Congenital Heart Defect Closure Devices, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.4 ... Read More
-
Post-Traumatic Stress Disorder (PTSD) Therapeutics
... Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Antidepressants, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.1 Billion by ... Read More
-
Prenatal Vitamin Supplements
... at a CAGR of 6.5% over the analysis period 2024-2030. Gummy, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$174.5 Million by the end of the ... Read More
-
Professional Dental Care
... at a CAGR of 4.0% over the analysis period 2024-2030. Toothbrush, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$266.5 Million by the end of the ... Read More
-
Proteases
... 5.5% over the analysis period 2024-2030. Microbes Source, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth ... Read More
-
Sanitary Valves
... CAGR of 3.4% over the analysis period 2024-2030. Control Valves, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$223.4 Million by the end of the analysis ... Read More
-
Congestive Heart Failure (CHF) Treatment Devices
... reach US$37.9 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Implantable Cardioverter Defibrillators, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and ... Read More
-
Life Science Analytics Market by Type (Descriptive, Prescriptive, Predictive), Service (Analytics), Application (Drug Discovery, Trials, RWE, Access, Sales & marketing, Drug Safety), End User (Pharma, Medical Device), & Region - Global Forecast to 2029
... grow as a result of the heterogenity & complexity of big data in life sciences, surging demand for technologically advanced analytical solutions for various applications across the industry, such as, research & development, commercialization (market ... Read More
-
Microencapsulation Market by Shell Material (Polymers, Gums & Resins, Lipids, Carbohydrates, Proteins), Technology, Core Material, Core Material Form, End-Use Industry, Functionality, and Region - Global Forecast to 2029
... AI technologies include advanced data analysis and predictive modeling that enables the manufacturers to achieve optimization of the microencapsulation techniques, mainly spray drying and coacervation. This can result in new formulations with tailored properties where ... Read More
-
Particle Therapy
... CAGR of 8.8% over the analysis period 2024-2030. Proton Therapy, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$2.3 Billion by the end of the analysis ... Read More
-
Microfluidics Market by Product (Chip, Sensor, Valve, Pump, Needle), Material (Silicon, Polymer), Application (Diagnostics (Clinical, PoC), Research (Proteomic, Genomics, Cell), Therapeutics (Drug Delivery, Wearables)), End User- Global Forecast to 2029
... to a number of important factors. The growing requirement for point-of-care diagnostics is one of an important factor. The necessity for fast and accurate diagnosis has risen due to the increase in chronic diseases like ... Read More
-
Vitamins
... 6.0% over the analysis period 2024-2030. Vitamin B, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.5 Billion by the end of the analysis period. Growth ... Read More
-
Stroke Management
... CAGR of 5.3% over the analysis period 2024-2030. Diagnostics Type, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$35.9 Billion by the end of the analysis ... Read More
-
Polyethylene Glycol Market by Grade, Form (Liquid, White wax, Flake/Powder), Package Size (Drums, Bulk Container, Glass Bottles), End-Use Industry (Pharmaceutical, Cosmetics & Personal care, Food & Beverage, Industrial) & Region - Global Forecast to 2029
... widely used for drug formulations and delivery systems in pharmaceutical industries. It enhances the solubility and bioavailability of poorly soluble drugs. Additionally, due to its low toxicity and non-irritating properties it is widely used in ... Read More
Research Assistance
